T B Starr

Summary

Country: USA

Publications

  1. ncbi Significant shortcomings of the U.S. Environmental Protection Agency's latest draft risk characterization for dioxin-like compounds
    T B Starr
    TBS Associates, 7500 Rainwater Road, Raleigh, North Carolina 27615, USA
    Toxicol Sci 64:7-13. 2001
  2. ncbi Significant issues raised by meta-analyses of cancer mortality and dioxin exposure
    Thomas B Starr
    TBS Associates, 7500 Rainwater Road, Raleigh, NC 27615 3700, USA
    Environ Health Perspect 111:1443-7. 2003
  3. ncbi A proposed inhalation reference concentration for methanol
    Thomas B Starr
    TBS Associates, 7500 Rainwater Road, Raleigh, NC 27615 3700, USA
    Regul Toxicol Pharmacol 38:224-31. 2003
  4. ncbi A risk assessment for occupational acrylonitrile exposure using epidemiology data
    Thomas B Starr
    TBS Associates, Raleigh, NC 27615 3700, USA
    Risk Anal 24:587-601. 2004
  5. ncbi Workshop overview: reassessment of the cancer risk of dichloromethane in humans
    Thomas B Starr
    TBS Associates, Raleigh, North Carolina 27615, USA
    Toxicol Sci 91:20-8. 2006
  6. ncbi TCDD exposure-response analysis and risk assessment
    Hong Cheng
    Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, USA
    Risk Anal 26:1059-71. 2006
  7. ncbi Exposure reconstruction for the TCDD-exposed NIOSH cohort using a concentration- and age-dependent model of elimination
    Lesa L Aylward
    Exponent, Inc, Alexandria, VA 22314, USA
    Risk Anal 25:945-56. 2005
  8. ncbi Humans appear no more sensitive than laboratory animals to the inhibition of red blood cell cholinesterase by dichlorvos
    Judith A MacGregor
    Toxicology Consulting Services, Arnold, MD, USA
    Regul Toxicol Pharmacol 43:150-67. 2005
  9. ncbi Uses of benchmark dose methodology in quantitative risk assessment
    Thomas B Starr
    Regul Toxicol Pharmacol 42:1-2. 2005
  10. ncbi Probabilistic dose-response modeling: case study using dichloromethane PBPK model results
    Dale J Marino
    Health, Safety and Environment, Eastman Kodak Company, 1999 Lake Avenue, Rochester, NY 14650, USA
    Regul Toxicol Pharmacol 49:285-300. 2007

Collaborators

Detail Information

Publications10

  1. ncbi Significant shortcomings of the U.S. Environmental Protection Agency's latest draft risk characterization for dioxin-like compounds
    T B Starr
    TBS Associates, 7500 Rainwater Road, Raleigh, North Carolina 27615, USA
    Toxicol Sci 64:7-13. 2001
    ..Although the epidemiology data used by U.S. EPA are consistent with a significant elevation in all-cancer mortality, by about 32%, among TCDD-exposed workers, this elevation should not be attributed to the workers' TCDD exposure...
  2. ncbi Significant issues raised by meta-analyses of cancer mortality and dioxin exposure
    Thomas B Starr
    TBS Associates, 7500 Rainwater Road, Raleigh, NC 27615 3700, USA
    Environ Health Perspect 111:1443-7. 2003
    ....
  3. ncbi A proposed inhalation reference concentration for methanol
    Thomas B Starr
    TBS Associates, 7500 Rainwater Road, Raleigh, NC 27615 3700, USA
    Regul Toxicol Pharmacol 38:224-31. 2003
    ..The resulting maximum likelihood estimate for the inhalation RfC was 298 mg/m3, with a 95% lower confidence bound of 135 mg/m3...
  4. ncbi A risk assessment for occupational acrylonitrile exposure using epidemiology data
    Thomas B Starr
    TBS Associates, Raleigh, NC 27615 3700, USA
    Risk Anal 24:587-601. 2004
    ....
  5. ncbi Workshop overview: reassessment of the cancer risk of dichloromethane in humans
    Thomas B Starr
    TBS Associates, Raleigh, North Carolina 27615, USA
    Toxicol Sci 91:20-8. 2006
    ..Overall, the panel concluded that the new models for DCM risk assessment were scientifically and technically sound and represented an advance over those employed in past assessments...
  6. ncbi TCDD exposure-response analysis and risk assessment
    Hong Cheng
    Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, USA
    Risk Anal 26:1059-71. 2006
    ....
  7. ncbi Exposure reconstruction for the TCDD-exposed NIOSH cohort using a concentration- and age-dependent model of elimination
    Lesa L Aylward
    Exponent, Inc, Alexandria, VA 22314, USA
    Risk Anal 25:945-56. 2005
    ....
  8. ncbi Humans appear no more sensitive than laboratory animals to the inhibition of red blood cell cholinesterase by dichlorvos
    Judith A MacGregor
    Toxicology Consulting Services, Arnold, MD, USA
    Regul Toxicol Pharmacol 43:150-67. 2005
    ....
  9. ncbi Uses of benchmark dose methodology in quantitative risk assessment
    Thomas B Starr
    Regul Toxicol Pharmacol 42:1-2. 2005
  10. ncbi Probabilistic dose-response modeling: case study using dichloromethane PBPK model results
    Dale J Marino
    Health, Safety and Environment, Eastman Kodak Company, 1999 Lake Avenue, Rochester, NY 14650, USA
    Regul Toxicol Pharmacol 49:285-300. 2007
    ..Given the variety of different approaches involved, 95th percentile-to-mean risk estimate ratios of 2.1-4.1 represent reasonable bounds on variability estimates regarding probabilistic assessments of DCM...